Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases

Margaret Markiewicz1, Erin Richard, Natalia Marks

  • 1Division of Rheumatology and Immunology, Medical University of South Carolina, 114 Doughty Street, STB, Charleston, SC 29425, USA.

Journal of Aging Research
|November 30, 2013
PubMed

Insights

Endothelial microparticles (EMPs) are key to vascular health and disease. This review explores how factors like lower estrogen levels trigger EMPs, impacting age-related vascular conditions.

Area of Science:

  • Vascular Biology and Medicine
  • Cellular Biology
  • Biomarkers and Disease Pathogenesis

Background:

  • Endothelial microparticles (EMPs) are vesicles from activated or apoptotic endothelial cells.
  • EMPs influence inflammation, coagulation, and angiogenesis, crucial for vascular function.
  • Elevated EMPs are linked to age-related vascular diseases like coronary artery disease and cerebral ischemia.

Purpose of the Study:

  • To review the multifaceted roles of EMPs in vascular health and disease.
  • To elucidate the mechanisms driving EMP formation, especially in aging populations.
  • To highlight EMPs as both biomarkers and effectors of vascular damage.

Main Methods:

  • Literature review of studies on endothelial microparticles.
  • Analysis of factors influencing EMP generation and release.
  • Synthesis of current understanding of EMPs in age-related vascular pathology.

Main Results:

  • EMPs are significant mediators in vascular pathophysiology.
  • Circulating EMP levels increase in various age-related vascular conditions.
  • Decreased estrogen, thrombin, and PAI-1 are identified as key inducers of EMPs.

Conclusions:

  • EMPs are critical players in the pathogenesis of vascular diseases.
  • Understanding EMP formation mechanisms is vital for therapeutic strategies.
  • Targeting EMPs offers potential for managing age-related vascular damage.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Inflammation01:38

Inflammation

Overview
46.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
663